Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Orthostatic intolerance is the development of disabling symptoms upon assuming an upright posture that are relieved partially by resuming the supine position. Postural tachycardia syndrome (POTS) is an orthostatic intolerance syndrome characterized by palpitations because of excessive orthostatic sinus tachycardia, lightheadedness, tremor, and near-syncope. Patients usually undergo extensive medical, cardiac, endocrine, neurologic, and psychiatric evaluation, which usually fails to identify a specific abnormality. The authors investigated the autonomic and hemodynamic profile of patients with POTS and the effectiveness of bisoprolol and fludrocortisone. The authors evaluated 11 female patients with POTS before and after medical treatment with a cardioselective bisoprolol beta-blocker or fludrocortisone, or both, and 11 age-matched control patients. Variability of heart rate and systolic blood pressure was assessed by fast Fourier transform, and spontaneous baroreceptor gain was assessed by use of the temporal sequences slope and alpha index. Modelflow was used to quantify hemodynamics. Symptoms in all patients improved greatly after medication. The autonomic and hemodynamic impairment observed in patients with POTS, particularly after orthostatic stress, is treated effectively with bisoprolol or fludrocortisone or both. These results need further confirmation in a controlled double-blind study. Proper medical treatment improves dramatically the clinical and autonomic-hemodyna…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beta-blockers have been reported to improve symptoms in case-reports 10, 11 and open-label studies 12, 13 and can decrease plasma norepinephrine levels in a hyperadrenergic state 14.”
From Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More (2009) · cites this paper as [12]
Citations
Cites
Welch, P. (1967) · IEEE Transactions on Audio and Electroacoustics · doi:10.1109/tau.1967.1161901 · Cited by 12,277 · cited 1×
“Spectral analysis was performed by use of the nonparametric Welch method [8].”
MethodPagani, M., Lombardi, F., Guzzetti, S., Rimoldi, O., Furlan, R., Pizzinelli, P., Sandrone, G., Malfatto, G., Dell'Orto, S., & Piccaluga, E. (1986) · Circulation Research · doi:10.1161/01.res.59.2.178 · Cited by 4,130
Computation of aortic flow from pressure in humans using a nonlinear, three-element model
Wesseling, K. H., Jansen, J. R., Settels, J. J., & Schreuder, J. J. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.74.5.2566 · Cited by 1,137 · cited 2×
“Calculation of noninvasive hemodynamics To estimate cardiac output and total peripheral resistance, we chose a method developed by Wesseling [14] because of its simplicity, low cost, and noninvasive nature.”
MethodSympathovagal Balance: A Critical Appraisal
Eckberg, D. L. (1997) · Circulation · doi:10.1161/01.cir.96.9.3224 · Cited by 1,087 · cited 2×
“The autonomic indices observed in our study confirm the suggestions of Novak et al. [23] and Eckeberg [ 10 ] that the HF spectral component of the R-R interval is a good marker of vagal tonic activity and that the LF component of the R-R interval is not an index of sympathetic activity, even after normalization becaus…”
MethodResultInfluentialParati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
Postural tachycardia syndrome (POTS)
Lamotte, G., & Low, P. A. (2023) · Primer on the Autonomic Nervous System · doi:10.1016/b978-0-323-85492-4.00118-6 · Cited by 300
Sleight, P., La Rovere, M. T., Mortara, A., Pinna, G., Maestri, R., Leuzzi, S., Bianchini, B., Tavazzi, L., & Bernardi, L. (1995) · Clinical Science · doi:10.1042/cs0880103 · Cited by 289
Chronic Orthostatic Intolerance: A Disorder With Discordant Cardiac and Vascular Sympathetic Control
Furlan, R., Jacob, G., Snell, M., Robertson, D., Porta, A., Harris, P., & Mosqueda-Garcia, R. (1998) · Circulation · doi:10.1161/01.cir.98.20.2154 · Cited by 229
Cerutti, C., Barres, C., & Paultre, C. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.5.h1993 · Cited by 226
Omboni, S., Parati, G., Frattola, A., Mutti, E., Di Rienzo, M., Castiglioni, P., & Mancia, G. (1993) · Hypertension · doi:10.1161/01.hyp.22.1.26 · Cited by 224 · cited 1×
“All Finapres recordings were made at the heart level [5].”
Background
Research works printed but not linked: 1
- Freitas J, Almeida J, Azevedo E, et al. Intolerância ortostatica-revisao e caso clinico.Rev Port Cardiol 1998;17:715–720.
Cited by
Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kuck, K. H., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 689
Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370
Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management
Fedorowski, A. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12852 · Cited by 352
Vernino, S., Bourne, K. M., Stiles, L. E., Grubb, B. P., Fedorowski, A., Stewart, J. M., Arnold, A. C., Pace, L. A., Axelsson, J., Boris, J. R., et al. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102828 · Cited by 304
Postural tachycardia syndrome—current experience and concepts
Mathias, C. J., Low, D. A., Iodice, V., Owens, A. P., Kirbis, M., & Grahame, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.187 · Cited by 251
Raj, S. R., Black, B. K., Biaggioni, I., Paranjape, S. Y., Ramirez, M., Dupont, W. D., & Robertson, D. (2009) · Circulation · doi:10.1161/circulationaha.108.846501 · Cited by 225
Raj, S. R., Guzman, J. C., Harvey, P., Richer, L., Schondorf, R., Seifer, C., Thibodeau-Jarry, N., & Sheldon, R. S. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.12.024 · Cited by 223
Pediatric Disorders of Orthostatic Intolerance
Stewart, J. M., Boris, J. R., Chelimsky, G., Fischer, P. R., Fortunato, J. E., Grubb, B. P., Heyer, G. L., Jarjour, I. T., Medow, M. S., Numan, M. T., et al. (2018) · Pediatrics · doi:10.1542/peds.2017-1673 · Cited by 222
Steroids: pharmacology, complications, and practice delivery issues.
Ericson-Neilsen, W., & Kaye, A. D. (2014) · PubMed · Cited by 306
Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A., & Robertson, D. (2005) · Circulation · doi:10.1161/circulationaha.104.497594 · Cited by 171
Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden
Fedorowski, A., Fanciulli, A., Raj, S. R., Sheldon, R. S., Shibao, C. A., & Sutton, R. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00962-3 · Cited by 154
“Data from a randomized trial suggest a benefit in suppressing recurrent vasovagal syncope 168 , but the data for its use in patients with POTS are sparse 169 .”
Postural orthostatic tachycardia syndrome
Agarwal, A. K., Garg, R., Ritch, A., & Sarkar, P. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.055046 · Cited by 126
Postural orthostatic tachycardia syndrome: mechanisms and new therapies
Mar, P. L., & Raj, S. R. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-041818-011630 · Cited by 122
Adolescent Fatigue, POTS, and Recovery: A Guide for Clinicians
Kizilbash, S. J., Ahrens, S. P., Bruce, B. K., Chelimsky, G., Driscoll, S. W., Harbeck-Weber, C., Lloyd, R. M., Mack, K. J., Nelson, D. E., Ninis, N., et al. (2014) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2013.12.014 · Cited by 120
Antipsychotic Pharmacotherapy and Orthostatic Hypotension
Gugger, J. J. (2011) · CNS Drugs · doi:10.2165/11591710-000000000-00000 · Cited by 74
Pharmacotherapy for postural tachycardia syndrome
Miller, A. J., & Raj, S. R. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.04.008 · Cited by 91
Stewart, J. M., Glover, J. L., & Medow, M. S. (2006) · Clinical Science · doi:10.1042/cs20050254 · Cited by 77
A review of postural orthostatic tachycardia syndrome
Carew, S., Connor, M. O., Cooke, J., Conway, R., Sheehy, C., Costelloe, A., & Lyons, D. (2008) · Europace · doi:10.1093/europace/eun324 · Cited by 73
“It promotes sodium and fluid retention and improves sensitivity of peripheral alpha-adrenergic receptors.49 Fludrocortisone or bisoprolol or both improved the symptoms and haemodynamic abnormalities in a group of 11 patients with POTS.50 Side effects include hypokalaemia, hypomagnesaemia, hypertension, and peripheral…”
BackgroundInfluentialReynolds, G. K., Lewis, D. P., Richardson, A. M., & Lidbury, B. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12161 · Cited by 70
Efficacy of Therapies for Postural Tachycardia Syndrome: A Systematic Review and Meta-analysis
Wells, R., Elliott, A. D., Mahajan, R., Page, A., Iodice, V., Sanders, P., & Lau, D. H. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.01.025 · Cited by 67
Leonetti, P., Audat, F., Girard, A., Laude, D., Lefr�re, F., & Elghozi, J. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-0191-1 · Cited by 58
Neuronal and hormonal perturbations in postural tachycardia syndrome
Mar, P. L., & Raj, S. R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00220 · Cited by 52
Postural syncope: mechanisms and management
Vaddadi, G., Lambert, E., Corcoran, S. J., & Esler, M. D. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01248.x · Cited by 48
Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?
Yusuf, S., & Camm, A. J. (2003) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840300800202 · Cited by 48
Zhang, Q., Chen, X., Li, J., & Du, J. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0249-3 · Cited by 44
“β-blockers have been reported to improve symptoms in case reports and open-label studies [6-10].”
Moon, J., Kim, D.-Y., Lee, W.-J., Lee, H. S., Lim, J.-A., Kim, T.-J., Jun, J.-S., Park, B., Byun, J.-I., Sunwoo, J.-S., et al. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0612-9 · Cited by 40
Long-term follow-up of patients with postural tachycardia syndrome
Sousa, A., Lebreiro, A., Freitas, J., & Maciel, M. J. (2012) · Clinical Autonomic Research · doi:10.1007/s10286-011-0155-1 · Cited by 38
“Although selective beta1-adrenoreceptor blockade has been reported in literature, including our own experience [4], a more recent controlled trial (Raj SR, Circ 2009) showed that low-dose propranolol, a non-selective beta-blocker, may be more appropriate in treatment of POTS.”
BackgroundResultSelf-citationDiagnosis and management of postural orthostatic tachycardia syndrome: A brief review
Abed, H., Ball, P., & Wang, L. (2012) · 老年心脏病学杂志:英文版 · doi:10.3724/sp.j.1263.2012.00061 · Cited by 41
Deciphering the sinus tachycardias
Yusuf, S., & Camm, A. J. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280603 · Cited by 35
Evaluating and managing postural tachycardia syndrome
Lei, L. Y., Chew, D. S., Sheldon, R. S., & Raj, S. R. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.18002 · Cited by 28
“55 It is generally well tolerated, although possible adverse effects include hyperkalemia, hypertension, fatigue, nausea, headache, and edema.”
BackgroundMar, P. L., Raj, V., Black, B. K., Biaggioni, I., Shibao, C. A., Paranjape, S. Y., Dupont, W. D., Robertson, D., & Raj, S. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113512911 · Cited by 24
“Serotonin/norepinephrine reuptake inhibitors (SNRIs) are sometimes used in the management of POTS as second-line agents when more conventional medications such as fludrocortisone (Freitas et al., 2000), propranolol (Raj et al.”
BackgroundConway, A. E., Verdi, M., Shaker, M. S., Bernstein, J. A., Beamish, C., Morse, R., Madan, J. C., Lee, M. W., Sussman, G., Al-Nimr, A., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.03.019 · Cited by 24
Deng, X., Zhang, Y., Liao, Y., & Du, J. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00460 · Cited by 24
Boris, J. R., McClain, Z., & Bernadzikowski, T. (2019) · Transgender Health · doi:10.1089/trgh.2019.0041 · Cited by 24
Postural Tachycardia, Orthostatic Intolerance, and the Chronic Fatigue Syndrome
Grubb, B. P., Calkins, H. G., & Rowe, P. C. (2005) · Wiley eBooks · doi:10.1002/9780470994801.ch13 · Cited by 26
Clinical neurophysiology of postural tachycardia syndrome
Cutsforth‐Gregory, J. K., & Sandroni, P. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64142-7.00066-7 · Cited by 25
Abbate, G., Iulio, B. D., THOMAS, G. K., Priday, A. G., Biondi‐Zoccai, G., Markley, R., & Abbate, A. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001432 · Cited by 22
Zhang, Q., Xu, B., & Du, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00525 · Cited by 20
Postural Orthostatic Tachycardia Syndrome (POTS)
Mizumaki, K. (2011) · Journal of Arrhythmia · doi:10.1016/s1880-4276(11)80031-1 · Cited by 19
Hutt, E., Vajapey, R. S., Iterson, E. H. V., Jaeger, F. J., Cho, L., Ahmed, H. M., & Mayuga, K. A. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.06.013 · Cited by 20
Boris, J. R., & Bernadzikowski, T. (2018) · Cardiology in the Young · doi:10.1017/s1047951118001373 · Cited by 18
Ghazal, M., Akkawi, A. R., Fancher, A. J., Oundo, E., Tanzeem, H., Sajjad, L., & Briasoulis, Α. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102977 · Cited by 20
Postural orthostatic tachycardia syndrome (POTS)
Sidhu, B., Obiechina, N., Rattu, N., & Mitra, S. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-201244 · Cited by 15
Pierson, B. C., Apilado, K. P., Franzos, M. A., Allard, R. J., Mancuso, J. D., Tribble, D. R., Saunders, D., & Koehlmoos, T. P. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1515486 · Cited by 16
Dizziness and orthostatic intolerance in pediatric headache patients
Qubty, W., & Kedia, S. (2016) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2016.01.004 · Cited by 12
Treatment options for autonomic neuropathies
Gibbons, C. H., & Freeman, R. L. (2006) · Current Treatment Options in Neurology · doi:10.1007/s11940-006-0003-0 · Cited by 10
Postural Tachycardia Syndrome: Diagnosis and Management in Adolescents and Young Adults
Heyer, G. L. (2017) · Pediatric Annals · doi:10.3928/19382359-20170322-01 · Cited by 10
Blood Pressure Regulation in Post–COVID POTS: Beyond Sinus Tachycardia
Johansson, M., Ståhlberg, M., Ricci, F., Lewinter, C., Hamrefors, V., Nilsson, P. M., Sutton, R., & Fedorowski, A. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23670 · Cited by 9
“…and impaired vasoconstriction in POTS, some off-label therapeutics that address both vasculature (midodrine) 11 and blood volume control (fludrocortisone) 12 are applied, with weak rationale and without any detailed consideration given to baseline hemodynamics and the effects of therapy.”
Pharmacokinetics of Pyridostigmine in a Child With Postural Tachycardia Syndrome
Filler, G., Gow, R. M., Nadarajah, R., Jacob, P. J., Johnson, G., Zhang, Y., & Christians, U. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0904 · Cited by 9
Vasavada, A. M., Verma, D., Sheggari, V., Ghetiya, S., Chirumamilla, P. C., Kotak, R. A., Mahapatra, S. S., Patel, T., & Jain, M. (2023) · Cureus · doi:10.7759/cureus.38887 · Cited by 9
“(2000) [9] Observational study 11F 31 ± 11 Bisoprolol and/or fludrocortisone Patients were symptomatically better after drug therapy Outcomes with”
BackgroundMethodInfluentialLong COVID and hypermobility spectrum disorders have shared pathophysiology
Ganesh, R., & Munipalli, B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1455498 · Cited by 9
Non-Pharmacological and Pharmacological Management of Cardiac Dysautonomia Syndromes
Lakkireddy, D. (2019) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2395 · Cited by 7
Kanjwal, K., Karabin, B. L., Kanjwal, Y., & Grubb, B. P. (2009) · Cardiology Research and Practice · doi:10.4061/2009/187543 · Cited by 6
“These patients are usually treated with fludrocortisone [9] midodrine [10], methylphenidate [11], and selective serotonin reuptake inhibitors [12, 13].”
Freeman, R. L., & Kaufmann, H. (2007) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000299966.05395.6c · Cited by 7
“…IV phenylephrine (Stewart et al, 2002), midodrine (Gordon et al, 2000; Hoeldtke et al, 2006; Jacob et al, 1997b), octreotide (Hoeldtke et al, 2006), erythropoietin (Hoeldtke et al, 1995), pyridostigmine (Raj et al, 2005b), and beta-blockade (Abe et al, 2000; Freitas et al, 2000) have been reported.”
BackgroundLe syndrome de tachycardie posturale (PoTS) : une maladie pour l’interniste
Astudillo, L. M., Laure, A., Fabry, V., Pugnet, G., Maury, P., Labrunée, M., Sailler, L., & Traon, A. P. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.04.017 · Cited by 6
Prognosis of patients with postural tachycardia syndrome: a follow-up study
Kang, S., Kim, H. J., & Ko, K. H. (2019) · Annals of Clinical Neurophysiology · doi:10.14253/acn.2019.21.1.30 · Cited by 5
“Some useful treatment options exist, but many suggested treatments have poor evidence base.(2,11) The prognosis of patients with POTS is favorable according to a prior study, which found that 80% of patients improved and 60% had minimal residual symptoms over a duration of approximately five years.”
BackgroundAcute Water Ingestion as a Treatment for Postural Orthostatic Tachycardia Syndrome
Ziffra, J. B., & Olshansky, B. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.100206 · Cited by 4
Fineberg, D., Moreau, A., Schneider‐Futschik, E. K., & Armstrong, C. W. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00229 · Cited by 3
Horowitz, R. I., Fallon, J., & Freeman, P. R. (2023) · Microorganisms · doi:10.3390/microorganisms11092301 · Cited by 5
“The autonomic neuropathy with POTS in patient 21 was so severe that despite multiple medications used to treat POTS, including fludrocortisone (Florinef) [164], midodrine [165], droxidopa [166], Beta blockers [167], and ivabradine (Corlanor) [168], she was still unable to remain in an upright position for more than 10…”
BackgroundTreatment Updates in Postural Tachycardia Syndrome
Goodman, B. P. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00643-3 · Cited by 3
Postural orthostatic tachycardia syndrome
Graham, U., & Ritchie, K. M. (2009) · BMJ Case Reports · doi:10.1136/bcr.10.2008.1132 · Cited by 3
Harnish, P. R., Shastri, P., & Grubb, B. P. (2021) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2021.120503 · Cited by 3
Mh, K., Koseska, K., Borowicz, J., Górecki, B., Kloch, K., Romaniuk, P., Lohin, M.-K., Strawińska, A., & Bednarczyk, M. M. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.87.67414 · Cited by 2
Lin, Y., Yu, J. H., Lin, L., Cao, Y., Zhang, Y., Chen, S.-F., & Zheng, C.-Q. (2014) · Gene · doi:10.1016/j.gene.2014.01.081 · Cited by 2
RetractedGugger, J. J., & Ehret, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803376-0.00004-6 · Cited by 2
Berganzo, K., Tijero, B., Zarranz, J. J., & Gómez‐Esteban, J. C. (2013) · Neurología · doi:10.1016/j.nrl.2013.01.005 · Cited by 2
Dziedzic, A., Furtak, D., Grela, W., Niewiadomska, J., Głogowska, P., Tulej, D., Marciniuk, D., Gniaź, N., Górska, A., & Marko, N. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.71.56193 · Cited by 1
Water Ingestion in Postural Orthostatic Tachycardia Syndrome: A Feasible Treatment Option?
MEHDIRAD, A. A., FEIGOFSKY, S., Lei, L. Y., Sheikh, N. A., Raj, S. R., Kanjwal, K., & Cannom, D. S. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.100207 · Cited by 1
Desmopressin in the postural tachycardia syndrome
Weinstock, J. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.05.018 · Cited by 1
Orthostatic Hypotension and Autonomic Dysfunction Syndromes
Raj, S. R., & Robertson, D. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50150-2 · Cited by 1
Berganzo, K., Tijero, B., Zarranz, J. J., & Gómez‐Esteban, J. C. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.01.006
Hipertensión arterial episódica asociada al síndrome de taquicardia postural ortostática
Roca, E. C., Doménech, I., & Ferrer, E. L. (2006) · Anales de Pediatría · doi:10.1157/13094264
Zespół posturalnej tachykardii ortostatycznej. Definicja, diagnostyka różnicowa i leczenie
Ociessa, A., Niedziela, J. T., Goliszek, L., & Wasilewski, J. P. (2013) · Folia Cardiologica
A Difficult Diagnosis: POT Syndrome Presenting with Severe Abdominal Symptoms
(2008) · The Internet Journal of Cardiology · doi:10.5580/564
Updates in postural tachycardia syndrome
Moon, J. (2021) · Annals of Clinical Neurophysiology · doi:10.14253/acn.2021.23.1.1
Robertson, D. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1028974.343463
Steroids: Pharmacology, Difficulties and Practice Delivery Issues
Vishwakarma, P., Jain, P. K., Vishwakarma, P., Jain, A., & Khare, B. (2022) · International Journal of Medical Sciences and Pharma Research · doi:10.22270/ijmspr.v8i3.60 · Cited by 1
Postural orthostatic tachycardia syndrome
George, T., & Antonio, O. (2024) · InnovAiT Education and inspiration for general practice · doi:10.1177/17557380241288786 · Cited by 2
“If the patient continues to be symptomatic, a serotonin reuptake inhibitor, or a serotonin and noradrenaline reuptake inhibitor can be added (Freitas et al., 2000).”
Marchetta, M., Hogwood, A. C., Golino, M., Abbate, G., THOMAS, G. K., Markley, R., Stavrakis, S., Canada, J. M., & Abbate, A. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.10.007
Metadata
- Authors
- Freitas, J., Santos, R., Azevedo, E., Costa, O., Carvalho, M., & Falcão de Freitas, A.
- Affiliations
- Hospital de São João (PT)
- Universidade do Porto (PT)
- Corresponding author
- Freitas, João
- Venue
- Clinical Autonomic Research
- Published
- 2000-10
- Volume
- 10
- Issue
- 5
- Pages
- 293-299
- ISSN
- 0959-9851 (ISSN-L)
- 1619-1560
- OpenAlex
- W2028395470
- Cited by
- 78
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 2 · 2016: 2 · 2014: 6 · 2013: 5 · 2012: 3
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Autonomic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Keywords
- postural orthostatic tachycardia syndrome, orthostatic intolerance, bisoprolol, fludrocortisone, autonomic dysfunction, heart rate variability, hemodynamics, orthostatic stress, hypovolemia, beta-blockers, mineralocorticoids
- MeSH terms
- Adolescent, Adrenergic beta-Antagonists, Adult, Blood Pressure, Cardiac Output, Electrocardiography, Female, Fludrocortisone, Heart Rate, Humans, Hypotension, Orthostatic, Middle Aged, Mineralocorticoids, Posture, Pressoreceptors, Sympatholytics, Syndrome, Tachycardia, Treatment Outcome, Bisoprolol, Tilt-Table Test
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.